Please login to the form below

Not currently logged in

Biogen and Happify Health team up to create digital platform for MS patients

There are over 2.3 million people living with MS worldwide, with women being more likely to develop the condition than men


Biogen and Happify Health have revealed plans for a new collaboration to support people living with multiple sclerosis (MS), with the companies aiming to provide a digital solution for patient education and engagement, driven by artificial intelligence (AI).

The partnership is focused on helping those with MS to manage their care journey, improve their well-being and gain access to learning materials surrounding treatment options. There will also be opportunities to consult with experts and get support from others in the MS community.

Over 2.3 million people live with MS worldwide and this number includes over one million people in the US, according to data from the National MS Society. Women are two to three times more likely to develop the condition than men.

As a global leader in developing treatments for those living with chronic neurological and neurodegenerative diseases, Biogen is able to reinforce support for the new MS platform, which involves contributing educational content and resources for the patient care journey.

Commenting on the project, Jason Hawbecker, head of strategic partnerships and collaborations at Biogen, said: “This collaboration is one of many ways we are focused on supporting patients by meeting them where they are. The combination of Biogen’s expertise in neuroscience and our commitment to digital health, along with Happify Health’s AI and digital therapeutic capabilities will help drive a connected and comprehensive experience that allows patients to feel supported throughout their journey.”

The Happify Health platform uses a digital tool configured for MS and Kopa, providing health and wellness support with access to healthcare professionals.

The online community enables those living with MS to ask experts questions and discuss the physical and mental issues with patients at similar stages. The AI technology employed by Happify Health helps to tailor content to patients’ life stages, symptoms and interests.

MS is the third therapeutic area to be tackled via Happify Health's unique Sequence approach, in addition to its work in psoriasis and maternal health.

Sequences are configured to address and support specific medical conditions, while combining components like evidence-based digital therapeutics, online communities and coaching into one consolidated platform.

Article by
Fleur Jeffries

23rd June 2022

From: Healthcare



Subscribe to our email news alerts


Add my company
Six Degrees Medical Consulting

For over a decade, our medical communication services have helped pharmaceutical companies optimize their brand, disease and corporate objectives. Building...

Latest intelligence

Healing the Healers
Because if we do not heal the healers, who is going to heal us?...
The (inevitable) digital transformation of Medical Affairs
It’s not a question of ‘if,’ it’s a question of ‘when.’...
Oncology eBook: Reducing the care gap in cancer prevention, diagnosis, and treatment
Despite significant innovation in the oncology landscape, there is a growing care gap preventing patients accessing and benefiting from innovations in cancer treatment. In this new publication, our oncology experts...